Background: Surgeons may be reluctant to withdraw postoperative life support after a poor outcome. Methods: A cross-sectional random sample was taken from a US mail survey of 2100 surgeons who routinely perform high-risk operations. We used a hypothetical vignette of a specialty-specific operation complicated by a hemiplegic stroke and respiratory failure. On postoperative day 7, the patient and family requested withdrawal of life-supporting therapy. We experimentally modified the timing and role of surgeon error to assess their influence on surgeons' willingness to withdraw life-supporting care. Results: The adjusted response rate was 56%. Sixty-three percent of respondents would not honor the request to withdraw life-supporting treatment.
When the patient of an internist dies, his colleagues ask, "What happened?," when the patient of a surgeon dies, his colleagues ask, "What did you do?" -Charles Bosk, Forgive and Remember 1 S urgeons embrace an ethos of personal responsibility for the surgical patient. This strong history and tradition contribute to more than a century of success prolonging and improving patients' quality and length of life through operative intervention. However, despite a record of impressive surgical success, not all patients have good operative outcomes. Surgeons, arguably more than their nonsurgical colleagues, are acutely aware and personally sensitive to the risks and complications inherent in the treatments they provide, given the active role they assume in the provision of surgical therapy. [1] [2] [3] [4] Although this commitment to the surgical patient may be an essential component of care, in some settings, surgeons' personal responsibility may conflict with patients' autonomy. For example, before the policy of required reconsideration, do not resuscitate (DNR) orders were routinely suspended in the operating room, suggesting that patient autonomy would not be honored if a cardiac arrest was the direct result of surgery or anesthesia. [5] [6] [7] Our work 8 and that of others 9, 10 suggest that this surgical paternalism is linked to the issue of error and responsibility and is founded in the unique relationship between surgeon and patient. Most of what is known about this reluctance to withdraw life-support in surgery is based on qualitative studies 1, 2, 11 and anecdotal reporting. 12, 13 It is unknown how frequently surgeons will override a patient's or surrogate's request for withdrawal of aggressive care and what factors influence this decision.
We used clinical vignettes to examine potential conflict between surgeon error and patient autonomy in the context of highrisk operations where unfortunate outcomes are not uncommon. Our use of vignettes allowed us to experimentally examine the role that operative timing and surgeon error may play in surgeons' decisions to withdraw life-supporting therapy after an unwanted clinical outcome. We explicitly tested the association between surgeons' personal responsibility and decisions to withdraw life-supporting therapy in the setting of a postoperative complication.
METHODS

Participants and Incentives
We administered our survey to a randomly selected sample of Vascular, Cardiothoracic, and Neurosurgeons derived from membership lists of regional vascular surgery societies, the Society of Thoracic Surgeons, and the Cerebrovascular Section of the American Association of Neurological Surgeons. We selected these subspecialties to maximize the likelihood that participants routinely performed high-risk operations. We defined "high risk" throughout the survey as an operation with a procedural mortality greater than 1% or significant morbidity such as renal failure, major stroke, paralysis, or ventilator dependence.
In March 2010, we sent 2100 surveys, 700 per subspecialty group, to potential respondents. Each survey was packaged with a stamped return envelope and a laser-pointer pen valued at $2.85 as an incentive to encourage participation. A follow-up survey with stamped return envelope was sent to all nonrespondents. Because of a low response rate, a third survey was sent to nonresponding neurosurgeons after verifying addresses through Internet searches. We then added 180 members of the American Association of Neurological Surgeons to replace individuals from the first cohort whose addresses could not be verified.
We used the American Association for Public Opinion guidelines to calculate our response rate. 14 First, all surveys that were returned to sender without survey response and all surveys completed by ineligible respondents such as junior residents and nonsurgeons were removed. Next, we used an Internet search to estimate the percentage of nonrespondents who were ineligible due to faulty contact information by verifying the contact information of 60 respondents-20 from each subspecialty group-and 60 nonrespondents. We combined this eligibility information according to the American Association for Public Opinion standards to calculate the adjusted response rate.
Survey Design
We designed a survey to elicit factors that may influence a surgeon's decision to withdrawal life-supporting therapy postoperatively after a life-altering complication. We first conducted a qualitative study to identify themes and trends regarding surgeons' practices around the use of advance directives and withdrawal of lifesupporting therapy. We used semistructured interviews of surgeons and other physicians who routinely care for patients having highrisk operations. This study identified the importance of preoperative discussions, the influence of error and responsibility, and personal investment in the surgical patient as important factors for postoperative decisions about life-supporting therapy. 8, 15 Next, we developed survey questions to validate and generalize the results of our qualitative investigation.
We designed a vignette to assess surgeon response to a patient's request to withdraw life-supporting therapy after a difficult postoperative complication (see Supplemental Appendix, Supplemental Digital Content 1, http://links.lww.com/SLA/A251). The vignette featured a specialty specific operation and we used a 2 × 2 between-subject factorial design to assess the associations of interest (Table 1) . Thus, each surgeon received 1 of 4 vignette versions that modified the timing of the case (elective vs emergent) and the nature of the surgical com-plication (surgeon error vs happenstance). Our primary variable of interest was the surgeon's response to the patient's request to withdraw life-supporting therapy. We asked respondents how likely they would be to withdraw therapy using a 4-point Likert scale response frame ("Not at all Likely," "Somewhat Unlikely," "Somewhat Likely," and "Very Likely"). We also examined respondents' likelihood of asking the patient to wait for a short period of time (3 days) or for a prolonged period (10 days) to revisit the question of withdrawal of life-support. To understand factors that contributed to the surgeon's decision, we directly assessed the influence of 10 distinct factors on the surgeon's management of the patient's request to withdraw aggressive therapy. These factors include surgeon factors such as impact on performance measures and fear of litigation, institutional factors such as hospital resources invested in the patient's care, and patient factors such as the patient's ability to accurately predict the value of future health states.
The hypothetical vignette was piloted and pretested with 2 vascular surgeons, 1 neurosurgeon, and 1 cardiac surgeon for technical clarity and plausibility. In addition, all survey items were iteratively tested and modified using cognitive interviews with 6 surgeons who routinely perform high-risk operations but did not practice vascular, cardiac, or neurosurgery. The study was approved as exempt by institutional review boards at the University of Wisconsin and the University of Chicago and included a waiver of written consent.
Analysis
We entered data using Microsoft Excel with a 10% audit confirming that the accuracy of data entry was greater than 99%. We used descriptive statistics to examine the distribution of each variable. We defined our primary outcome as the surgeon's response to the patient's request for withdrawal of life-supporting therapy. For this analysis, we dichotomized responses by comparing "Not at all Likely" and "Somewhat Unlikely" with "Somewhat Likely" and "Very Likely." In sensitivity analyses, we examined the effect of different methods of categorizing this outcome variable, and findings were substantively unchanged using other methods of categorization. Next, we examined the bivariate association between the timing of the case, the nature of the surgical complication, surgeon-cited factors, and the surgeon's likelihood of honoring the patient's request to withdraw life-supporting therapy. Finally, we conducted stepwise multivariate logistic regression to identify factors independently associated with surgeons' decision to withdraw care. Our final models included the 
RESULTS Participants
A total of 912 completed surveys were returned. The adjusted response rate was 56% for vascular surgeons, 54% for cardiac surgeons, and 56% for neurosurgeons. A similar number of surveys were returned for each of the 4 randomly distributed vignettes. We found no significant difference in the willingness to withdraw life-supporting therapy between the early responders and the late responders to this survey, suggesting the absence of response-wave or nonresponse bias.
Nearly all surgeons reported performing at least one high-risk procedure per month (mean = 10.8, median = 8). The respondents were evenly split between private practice and academic practices and represented a broad range of practice experience ( Table 2 ). In response to the vignette featuring a patient requesting withdrawal of life-supporting therapy, 63% of surgeons reported they were "Not at all" or "Somewhat unlikely" to withdraw life-supporting therapy in this setting; 57% reported they were "Very Likely" or "Somewhat Likely" to wait 10 days to see if the patient's condition improved.
Factors Influencing the Decision to Withdraw Life-Supporting Therapy
On bivariate analysis, surgeons who were told the patient's complication was the result of surgeon error were significantly less likely to withdraw support than their colleagues who encountered a noniatrogenic complication (33% vs 41%, P = 0.008) (Figure 1) . Similarly, surgeons who had an elective operation were less likely to withdraw life-supporting therapy than those operating in an emergent setting (33% vs 41%, P = 0.01) ( Table 3 ). There were also differences in the likelihood of withdrawal of life-support based on several other surgeon characteristics. For example, cardiothoracic and neurosurgeons were significantly less likely to withdraw life-support than vascular surgeons (30 vs 37 vs 45%, respectively, P = 0.0006). In addition, surgeons who were less likely to withdraw life-supporting 238 (29) therapy were more likely to report personal optimism about the patient's future quality of life than their counterparts (79% vs 62%, P < 0.0001). There was no difference in reported concern about performance measures between surgeons who withdrew and did not withdraw life-supporting therapy (25% vs 27%, P = 0.54) ( Table 4) . On multivariate analyses, a strong and statistically significant association persisted between surgical timing, the surgeon's role in the poor outcome, and willingness to withdraw life-support. The odds of withdrawing life-sustaining therapy were nearly twofold as great among surgeons who encountered a complication that was not clearly the result of surgeon error during an emergency operation than among surgeons encountering a complication from surgeon error in the elective setting (odds ratio [OR] = 1.95, 95% confidence intervals [CIs] 1.26-3.01). In addition, the odds of withdrawing life-support were greater among those who did not express optimism about the patient's future quality of life (OR = 1.75, CI 1.11-2.50) and among those who were less concerned that the patient did not accurately value her future health state (OR 1.59, CI 1.11-2.27) than among their counterparts ( Table 5 ).
DISCUSSION
In this national study of surgeons, those faced with complications from surgical error during an elective operation were substantially less likely to withdraw life-supporting therapy than those managing a patient in whom a complication was not clearly from error and occurred in the setting of an emergency operation. Optimism about the patient's future quality of life and concern for the patient's ability to accurately predict her future health state were both associated with a surgeon's decision to delay withdrawal of postoperative life-support.
These findings are important because high-risk operations are performed frequently and little is known about the complex factors that influence the management of complications and requests for withdrawal of life-supporting therapy. Surgeons who feel responsible for the life of their patient and the role that they played in an unwanted outcome have difficulty relinquishing the goal of patient survival. Patients and other providers unaware of the surgeon's error and feelings of responsibility may then struggle to understand the surgeon's inability to change course and reconsider clinical goals. In The Silent World of Doctor and Patient, Jay Katz notes that " . . . physicians and patients bring their own vulnerabilities to the decision-making process. Both are authors and victims of their own conflicting motivations, interests and expectations." 16 Our findings demonstrate that in the setting of an unwanted postoperative outcome, a surgeon's emotion and accountability have inevitable clinical consequences for both surgeons and patients.
For surgeons, these data suggest that nonclinical factors may influence decision making about withdraw of life-supporting therapy. Ours is not the first study to suggest the importance of nonclinical factors that influence clinical decision-making; there is a large body of literature demonstrating how nonclinical patient characteristics, as well as features of physicians and structural aspects of care, may affect health care delivery. [17] [18] [19] [20] However, our study is unique in its examination of high-risk operations and the role that technical performance may play in guiding the management of postoperative life-supporting therapies. Iatrogenic complications that clearly derive from technical error during elective operations may pose considerable guilt and emotional burden upon surgeons. [21] [22] [23] It is understandable that such factors should weigh on the surgeon. However, our findings call into question the degree to which these factors may unduly interfere with a patient's ability to control his or her health care decisions. 24, 25 For patients and their families, these data suggest that surgeons who prognosticate in the setting of an elective operation complicated by technical error may be providing information that is overly influenced by an emotional response to the clinical situation rather than an unbiased interpretation of the relevant clinical data. Indeed physicians' subjective impressions about survival may have more impact on the decision to withdraw support in the critically ill patient than validated predictive models 26, 27 and physicians' tendency to be overly optimistic regarding the prognosis of terminally ill patients has been well described. 28 Our data suggest that commission of an error in surgical technique and prognostic optimism may present a challenge to patient autonomy. Particularly in settings in which there is disagreement between patients and their families and the treating physician, our findings highlight the importance of frank discourse and, when needed, consultation with other disinterested parties in order to navigate what may be difficult postoperative decision-making.
Recognition that the surgeon's emotional state may have a significant impact on patients' postoperative management also suggests the importance of efforts to alleviate surgeons' emotional strain while simultaneously respecting the fierce ethic of responsibility that surgeons possess for patients' outcomes. 1 While surgical Morbidity and Mortality (M&M) Conferences may be a forum for catharsis and education surrounding technical error, there are few, if any, other formal venues for surgeons to express the emotional burden of caring for the surgical patient. 22, [29] [30] [31] Furthermore, although efforts to improve quality and outcomes in surgery are essential, the goals of quality improvement should be distinct from the intrinsic goals of surgical therapy and from the value of the surgeon-patient relationship. The performance of an operation to save or improve quality of life is valuable to patients and their families even when the patient does not survive.
Our study had several limitations. First, as with all surveys, our findings may be subject to nonresponse bias. However, we did not find any evidence of response wave bias, and since our hypothetical vignette used an experimental design, it is unlikely that our main findings would be substantively affected by such bias. Second, we focused on Vascular, Cardiothoracic, and Neurosurgeons because of how commonly they perform high-risk operations. Although our findings may not be generalizable to surgeons in other fields such as general surgery or nonthoracic surgical oncology, we have no reason to believe otherwise. Third, our study design necessarily used a hypothetical vignette so that operative characteristics could be experimentally altered. Although vignettes cannot capture the complexity present in a real clinical case, evidence supports their use to examine physicians' clinical decision-making. 32 In conclusion, when a patient suffers a life-threatening complication and requests withdrawal of life-supporting therapy postoperatively, surgeons may be unlikely to withdraw life-supporting therapy without delay. These decisions are influenced by both the timing of surgery and whether the complication was the result of explicit technical error. In addition, these nonclinical factors may be associated with surgeons' optimism about the patient's postoperative quality of life. Future efforts to enhance shared decision making for critically ill surgical patients need to address nonclinical biases that influence decision making in the setting of surgical complications.
